Remove 2001 Remove Clinical Trials Remove Marijuana Remove Sleep
article thumbnail

Guest Post: Denmark’s pilot pharma trial attracts first-movers

Cannabis Law Report

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. They are learning quickly from the successes and failures in Canada’s legal medical cannabis program that has been active since 2001. Arundati Dandapani. Founder and CEO,

article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. In addition to serving on the Board of MAPS, he is also the Chairman of the Board of the Marijuana Policy Project. Drug Science.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

The search terms used were as follows: “medicinal cannabis”; “cannabis”; “marijuana”; “medic* marijuana”; and “medic* cannabis”. Only one article appeared in the MJA in 2000 and again in 2001. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. Conditions most frequently mentioned.